Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1998;32:972-975

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction (v36,p467)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Muldoon, M. F.
Right arrow Articles by Manuck, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muldoon, M. F.
Right arrow Articles by Manuck, S. B.

(Hypertension. 1998;32:972-975.)
© 1998 American Heart Association, Inc.


Scientific Contributions

Inverse Relationship Between Fenfluramine-Induced Prolactin Release and Blood Pressure in Humans

Matthew F. Muldoon; Alan F. Sved; Janine D. Flory; James M. Perel; Karen A. Matthews; Stephen B. Manuck

From the Center for Clinical Pharmacology (M.F.M.) and the Department of Psychiatry (J.M.P., K.A.M.), University of Pittsburgh School of Medicine, Penn; and the Departments of Neuroscience (A.F.S.) and Psychology (J.D.F., S.B.M.), University of Pittsburgh, Penn.

Abstract—Although substantial evidence from experimental animals suggests that augmentation and reduction in serotonergic neurotransmission both affect arterial blood pressure (BP), it is unknown whether "tonic" central serotonergic activity is related to resting BP variability in humans. We tested this hypothesis in a community sample by evaluating the relationship between resting BP and a neuropharmacologic index of brain serotonergic activity (the fenfluramine challenge test). Subjects were 270 generally healthy men and women aged 25 to 60 years who were not receiving prescribed antihypertensive or psychotropic medications. The sample included 216 non-Hispanic whites and 47 blacks. Resting systolic BP ranged from 85 to 161 mm Hg and diastolic from 58 to 98 mm Hg. Each subject received 0.55 to 0.65 mg/kg D,L-fenfluramine hydrochloride, and the plasma prolactin concentration was measured over 3.5 hours. Analyses revealed a linear, inverse relationship between the maximum fenfluramine-induced prolactin rise and systolic and diastolic BP in whites: r=-0.36 and r=-0.29, respectively (P<0.001 for both). These relationships were not observed in the black participants. In whites, the prolactin response to fenfluramine remained a significant predictor of systolic and diastolic BPs in multivariate models including age, gender, body mass index, physical activity, smoking, and alcohol consumption (P<=0.001). When compared with subjects in the highest quartile of prolactin response, individuals whose prolactin responses to fenfluramine comprised the lowest quartile were 2.6 times more likely to have a resting systolic/diastolic BP of >135/85 mm Hg. These data reveal that in white but not black adults, fenfluramine-induced prolactin release correlates inversely with BP and may indicate a role of central serotonergic activity in the pathogenesis of hypertension.


Key Words: blood pressure • central nervous system • serotonin • fenfluramine • prolactin




This article has been cited by other articles:


Home page
StrokeHome page
M. F. Muldoon, R. H. Mackey, K. Sutton-Tyrrell, J. D. Flory, B. G. Pollock, and S. B. Manuck
Lower Central Serotonergic Responsivity Is Associated With Preclinical Carotid Artery Atherosclerosis
Stroke, August 1, 2007; 38(8): 2228 - 2233.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. F. Muldoon, R. H. Mackey, K. V. Williams, M. T. Korytkowski, J. D. Flory, and S. B. Manuck
Low Central Nervous System Serotonergic Responsivity Is Associated with the Metabolic Syndrome and Physical Inactivity
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 266 - 271.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. D. Stocker, M. F. Muldoon, and A. F. Sved
Blunted Fenfluramine-Evoked Prolactin Secretion in Hypertensive Rats
Hypertension, October 1, 2003; 42(4): 719 - 724.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
J. M. McCaffery, M. Bleil, M. F. Pogue-Geile, R. E. Ferrell, and S. B. Manuck
Allelic Variation in the Serotonin Transporter Gene-Linked Polymorphic Region (5-HTTLPR) and Cardiovascular Reactivity in Young Adult Male and Female Twins of European-American Descent
Psychosom Med, September 1, 2003; 65(5): 721 - 728.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
K. A. Matthews, J. D. Flory, M. F. Muldoon, and S. B. Manuck
Does Socioeconomic Status Relate to Central Serotonergic Responsivity in Healthy Adults?
Psychosom Med, March 1, 2000; 62(2): 231 - 237.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
S. A. Everson, G. A. Kaplan, D. E. Goldberg, and J. T. Salonen
Hypertension Incidence Is Predicted by High Levels of Hopelessness in Finnish Men
Hypertension, February 1, 2000; 35(2): 561 - 567.
[Abstract] [Full Text] [PDF]